nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—HDAC9—hematologic cancer	0.206	0.608	CbGaD
Valproic Acid—HDAC9—Vorinostat—hematologic cancer	0.135	0.339	CbGbCtD
Valproic Acid—HDAC2—hematologic cancer	0.133	0.392	CbGaD
Valproic Acid—HDAC2—Vorinostat—hematologic cancer	0.0561	0.141	CbGbCtD
Valproic Acid—CYP2C18—Ifosfamide—hematologic cancer	0.0101	0.0254	CbGbCtD
Valproic Acid—CYP2A6—Methoxsalen—hematologic cancer	0.00676	0.0169	CbGbCtD
Valproic Acid—UGT1A9—Irinotecan—hematologic cancer	0.00605	0.0152	CbGbCtD
Valproic Acid—UGT2B7—Epirubicin—hematologic cancer	0.00589	0.0148	CbGbCtD
Valproic Acid—CYP1A2—Anagrelide—hematologic cancer	0.00577	0.0145	CbGbCtD
Valproic Acid—CYP2B6—Thiotepa—hematologic cancer	0.00566	0.0142	CbGbCtD
Valproic Acid—SLC16A1—Methotrexate—hematologic cancer	0.00558	0.014	CbGbCtD
Valproic Acid—PTGS1—Bortezomib—hematologic cancer	0.00549	0.0138	CbGbCtD
Valproic Acid—SLC22A8—Mercaptopurine—hematologic cancer	0.00512	0.0128	CbGbCtD
Valproic Acid—CYP2A6—Ifosfamide—hematologic cancer	0.00493	0.0124	CbGbCtD
Valproic Acid—PTGS1—Thalidomide—hematologic cancer	0.00478	0.012	CbGbCtD
Valproic Acid—PTGS1—Ifosfamide—hematologic cancer	0.00421	0.0106	CbGbCtD
Valproic Acid—PTGS1—Imatinib—hematologic cancer	0.00402	0.0101	CbGbCtD
Valproic Acid—CYP2C9—Bexarotene—hematologic cancer	0.00361	0.00904	CbGbCtD
Valproic Acid—CYP2A6—Prednisolone—hematologic cancer	0.00329	0.00824	CbGbCtD
Valproic Acid—CYP2B6—Ifosfamide—hematologic cancer	0.00321	0.00804	CbGbCtD
Valproic Acid—CYP2C8—Bortezomib—hematologic cancer	0.00317	0.00794	CbGbCtD
Valproic Acid—CYP3A5—Daunorubicin—hematologic cancer	0.00315	0.0079	CbGbCtD
Valproic Acid—CYP1A2—Carmustine—hematologic cancer	0.00303	0.0076	CbGbCtD
Valproic Acid—CYP2C9—Idarubicin—hematologic cancer	0.00299	0.00749	CbGbCtD
Valproic Acid—CYP3A5—Thalidomide—hematologic cancer	0.00287	0.0072	CbGbCtD
Valproic Acid—CYP2B6—Nilotinib—hematologic cancer	0.00279	0.00698	CbGbCtD
Valproic Acid—SLC22A7—Methotrexate—hematologic cancer	0.00274	0.00687	CbGbCtD
Valproic Acid—CYP3A5—Teniposide—hematologic cancer	0.00274	0.00687	CbGbCtD
Valproic Acid—CYP2C19—Bortezomib—hematologic cancer	0.00266	0.00667	CbGbCtD
Valproic Acid—CYP1A2—Methoxsalen—hematologic cancer	0.00258	0.00647	CbGbCtD
Valproic Acid—CYP3A5—Ifosfamide—hematologic cancer	0.00253	0.00634	CbGbCtD
Valproic Acid—CYP1A2—Bortezomib—hematologic cancer	0.00245	0.00615	CbGbCtD
Valproic Acid—CYP2C8—Ifosfamide—hematologic cancer	0.00243	0.00609	CbGbCtD
Valproic Acid—CYP3A5—Imatinib—hematologic cancer	0.00242	0.00605	CbGbCtD
Valproic Acid—CYP1A2—Daunorubicin—hematologic cancer	0.00235	0.00588	CbGbCtD
Valproic Acid—CYP2C19—Thalidomide—hematologic cancer	0.00232	0.00581	CbGbCtD
Valproic Acid—CYP1A2—Alitretinoin—hematologic cancer	0.0023	0.00576	CbGbCtD
Valproic Acid—CYP2C9—Bortezomib—hematologic cancer	0.00221	0.00554	CbGbCtD
Valproic Acid—CYP2C19—Teniposide—hematologic cancer	0.00221	0.00554	CbGbCtD
Valproic Acid—CYP1A2—Thalidomide—hematologic cancer	0.00214	0.00536	CbGbCtD
Valproic Acid—CYP2C8—Nilotinib—hematologic cancer	0.00211	0.00529	CbGbCtD
Valproic Acid—CYP3A4—Bexarotene—hematologic cancer	0.0021	0.00526	CbGbCtD
Valproic Acid—CYP2C19—Ifosfamide—hematologic cancer	0.00204	0.00511	CbGbCtD
Valproic Acid—PTGS1—Etoposide—hematologic cancer	0.00201	0.00505	CbGbCtD
Valproic Acid—CYP3A4—Lomustine—hematologic cancer	0.00195	0.00489	CbGbCtD
Valproic Acid—CYP3A4—Busulfan—hematologic cancer	0.00195	0.00489	CbGbCtD
Valproic Acid—CYP2C19—Imatinib—hematologic cancer	0.00195	0.00488	CbGbCtD
Valproic Acid—CYP3A5—Dasatinib—hematologic cancer	0.00194	0.00486	CbGbCtD
Valproic Acid—CYP2A6—Dexamethasone—hematologic cancer	0.00194	0.00486	CbGbCtD
Valproic Acid—CYP2C9—Thalidomide—hematologic cancer	0.00193	0.00483	CbGbCtD
Valproic Acid—CYP2B6—Irinotecan—hematologic cancer	0.00191	0.0048	CbGbCtD
Valproic Acid—CYP1A2—Dacarbazine—hematologic cancer	0.00184	0.00461	CbGbCtD
Valproic Acid—CYP2C9—Teniposide—hematologic cancer	0.00184	0.00461	CbGbCtD
Valproic Acid—CYP1A2—Imatinib—hematologic cancer	0.0018	0.00451	CbGbCtD
Valproic Acid—CYP3A4—Thiotepa—hematologic cancer	0.00174	0.00436	CbGbCtD
Valproic Acid—CYP2C9—Ifosfamide—hematologic cancer	0.0017	0.00425	CbGbCtD
Valproic Acid—SLC22A8—Methotrexate—hematologic cancer	0.00167	0.0042	CbGbCtD
Valproic Acid—CYP2C9—Imatinib—hematologic cancer	0.00162	0.00406	CbGbCtD
Valproic Acid—CYP2B6—Cisplatin—hematologic cancer	0.00156	0.00391	CbGbCtD
Valproic Acid—CYP3A5—Irinotecan—hematologic cancer	0.00151	0.00378	CbGbCtD
Valproic Acid—CYP2C9—Nilotinib—hematologic cancer	0.00147	0.00369	CbGbCtD
Valproic Acid—CYP1A2—Dasatinib—hematologic cancer	0.00144	0.00362	CbGbCtD
Valproic Acid—OGDH—hematopoietic system—hematologic cancer	0.00137	0.0383	CbGeAlD
Valproic Acid—CYP3A4—Methoxsalen—hematologic cancer	0.00135	0.00339	CbGbCtD
Valproic Acid—CYP3A5—Vincristine—hematologic cancer	0.00132	0.00331	CbGbCtD
Valproic Acid—CYP3A4—Bortezomib—hematologic cancer	0.00129	0.00322	CbGbCtD
Valproic Acid—CYP2C19—Prednisone—hematologic cancer	0.00128	0.00322	CbGbCtD
Valproic Acid—CYP2B6—Dexamethasone—hematologic cancer	0.00126	0.00316	CbGbCtD
Valproic Acid—CYP3A4—Daunorubicin—hematologic cancer	0.00123	0.00308	CbGbCtD
Valproic Acid—CYP3A5—Etoposide—hematologic cancer	0.00121	0.00303	CbGbCtD
Valproic Acid—HDAC9—hematopoietic system—hematologic cancer	0.00121	0.0337	CbGeAlD
Valproic Acid—SLC22A6—Methotrexate—hematologic cancer	0.00117	0.00292	CbGbCtD
Valproic Acid—CYP2C8—Etoposide—hematologic cancer	0.00116	0.00291	CbGbCtD
Valproic Acid—UGT1A4—hematopoietic system—hematologic cancer	0.00111	0.0312	CbGeAlD
Valproic Acid—CYP3A4—Cytarabine—hematologic cancer	0.00108	0.00272	CbGbCtD
Valproic Acid—CYP3A4—Teniposide—hematologic cancer	0.00107	0.00268	CbGbCtD
Valproic Acid—CYP2B6—Doxorubicin—hematologic cancer	0.00105	0.00262	CbGbCtD
Valproic Acid—OGDH—gonad—hematologic cancer	0.00104	0.0291	CbGeAlD
Valproic Acid—CYP3A5—Dexamethasone—hematologic cancer	0.000993	0.00249	CbGbCtD
Valproic Acid—CYP3A4—Ifosfamide—hematologic cancer	0.000986	0.00247	CbGbCtD
Valproic Acid—ALDH5A1—hematopoietic system—hematologic cancer	0.000956	0.0268	CbGeAlD
Valproic Acid—CYP2C8—Dexamethasone—hematologic cancer	0.000955	0.00239	CbGbCtD
Valproic Acid—UGT1A6—testis—hematologic cancer	0.000948	0.0265	CbGeAlD
Valproic Acid—CYP3A4—Imatinib—hematologic cancer	0.000942	0.00236	CbGbCtD
Valproic Acid—OGDH—blood—hematologic cancer	0.000906	0.0254	CbGeAlD
Valproic Acid—CYP1A2—Etoposide—hematologic cancer	0.000899	0.00225	CbGbCtD
Valproic Acid—CYP3A4—Ruxolitinib—hematologic cancer	0.000887	0.00222	CbGbCtD
Valproic Acid—OGDH—bone marrow—hematologic cancer	0.000876	0.0245	CbGeAlD
Valproic Acid—CYP3A4—Nilotinib—hematologic cancer	0.000856	0.00215	CbGbCtD
Valproic Acid—CYP3A4—Vinorelbine—hematologic cancer	0.000849	0.00213	CbGbCtD
Valproic Acid—CYP2C9—Cisplatin—hematologic cancer	0.000825	0.00207	CbGbCtD
Valproic Acid—CYP2C19—Dexamethasone—hematologic cancer	0.000801	0.00201	CbGbCtD
Valproic Acid—HDAC9—blood—hematologic cancer	0.000798	0.0224	CbGeAlD
Valproic Acid—OGDH—lung—hematologic cancer	0.000794	0.0222	CbGeAlD
Valproic Acid—CYP3A4—Triamcinolone—hematologic cancer	0.000776	0.00195	CbGbCtD
Valproic Acid—HDAC9—bone marrow—hematologic cancer	0.000773	0.0216	CbGeAlD
Valproic Acid—CYP3A4—Dasatinib—hematologic cancer	0.000756	0.0019	CbGbCtD
Valproic Acid—OGDH—testis—hematologic cancer	0.000749	0.021	CbGeAlD
Valproic Acid—CYP3A4—Mitoxantrone—hematologic cancer	0.000747	0.00187	CbGbCtD
Valproic Acid—UGT1A4—blood—hematologic cancer	0.000738	0.0207	CbGeAlD
Valproic Acid—ALDH5A1—gonad—hematologic cancer	0.000727	0.0204	CbGeAlD
Valproic Acid—ACADSB—blood—hematologic cancer	0.000719	0.0201	CbGeAlD
Valproic Acid—HDAC9—lung—hematologic cancer	0.0007	0.0196	CbGeAlD
Valproic Acid—ACADSB—bone marrow—hematologic cancer	0.000696	0.0195	CbGeAlD
Valproic Acid—CYP2C9—Dexamethasone—hematologic cancer	0.000666	0.00167	CbGbCtD
Valproic Acid—CYP3A4—Betamethasone—hematologic cancer	0.000666	0.00167	CbGbCtD
Valproic Acid—HDAC9—testis—hematologic cancer	0.00066	0.0185	CbGeAlD
Valproic Acid—CYP3A4—Prednisolone—hematologic cancer	0.000657	0.00165	CbGbCtD
Valproic Acid—ALDH5A1—blood—hematologic cancer	0.000633	0.0177	CbGeAlD
Valproic Acid—ACADSB—lung—hematologic cancer	0.000631	0.0177	CbGeAlD
Valproic Acid—ABAT—gonad—hematologic cancer	0.000622	0.0174	CbGeAlD
Valproic Acid—CYP3A4—Prednisone—hematologic cancer	0.000621	0.00156	CbGbCtD
Valproic Acid—HDAC2—hematopoietic system—hematologic cancer	0.000616	0.0173	CbGeAlD
Valproic Acid—ALDH5A1—bone marrow—hematologic cancer	0.000613	0.0172	CbGeAlD
Valproic Acid—ACADSB—testis—hematologic cancer	0.000595	0.0167	CbGeAlD
Valproic Acid—CYP3A4—Irinotecan—hematologic cancer	0.000588	0.00147	CbGbCtD
Valproic Acid—ALDH5A1—lung—hematologic cancer	0.000555	0.0155	CbGeAlD
Valproic Acid—SLC16A1—hematopoietic system—hematologic cancer	0.000547	0.0153	CbGeAlD
Valproic Acid—OGDH—lymph node—hematologic cancer	0.000543	0.0152	CbGeAlD
Valproic Acid—ABAT—blood—hematologic cancer	0.000542	0.0152	CbGeAlD
Valproic Acid—ALDH5A1—testis—hematologic cancer	0.000524	0.0147	CbGeAlD
Valproic Acid—CYP3A4—Vinblastine—hematologic cancer	0.000523	0.00131	CbGbCtD
Valproic Acid—CYP3A4—Vincristine—hematologic cancer	0.000514	0.00129	CbGbCtD
Valproic Acid—ALDH5A1—Vinblastine—Vinorelbine—hematologic cancer	0.000512	0.315	CbGdCrCtD
Valproic Acid—HDAC9—lymph node—hematologic cancer	0.000479	0.0134	CbGeAlD
Valproic Acid—ABAT—lung—hematologic cancer	0.000475	0.0133	CbGeAlD
Valproic Acid—CYP3A4—Etoposide—hematologic cancer	0.000471	0.00118	CbGbCtD
Valproic Acid—HDAC2—gonad—hematologic cancer	0.000468	0.0131	CbGeAlD
Valproic Acid—ABAT—testis—hematologic cancer	0.000448	0.0126	CbGeAlD
Valproic Acid—ACADSB—lymph node—hematologic cancer	0.000431	0.0121	CbGeAlD
Valproic Acid—SLC16A1—gonad—hematologic cancer	0.000416	0.0117	CbGeAlD
Valproic Acid—SLC22A8—hematopoietic system—hematologic cancer	0.000414	0.0116	CbGeAlD
Valproic Acid—UGT2B7—testis—hematologic cancer	0.000413	0.0116	CbGeAlD
Valproic Acid—ALDH5A1—Vinblastine—Vincristine—hematologic cancer	0.000409	0.252	CbGdCrCtD
Valproic Acid—HDAC2—blood—hematologic cancer	0.000408	0.0114	CbGeAlD
Valproic Acid—HDAC2—bone marrow—hematologic cancer	0.000395	0.0111	CbGeAlD
Valproic Acid—SLC22A7—testis—hematologic cancer	0.000392	0.011	CbGeAlD
Valproic Acid—CYP3A4—Dexamethasone—hematologic cancer	0.000387	0.000971	CbGbCtD
Valproic Acid—ALDH5A1—lymph node—hematologic cancer	0.00038	0.0106	CbGeAlD
Valproic Acid—HDAC2—lung—hematologic cancer	0.000358	0.01	CbGeAlD
Valproic Acid—HDAC2—Topotecan—Irinotecan—hematologic cancer	0.000348	0.214	CbGdCrCtD
Valproic Acid—CYP2C19—hematopoietic system—hematologic cancer	0.000347	0.00972	CbGeAlD
Valproic Acid—HDAC2—testis—hematologic cancer	0.000338	0.00945	CbGeAlD
Valproic Acid—ABAT—lymph node—hematologic cancer	0.000325	0.0091	CbGeAlD
Valproic Acid—CYP3A4—Doxorubicin—hematologic cancer	0.000321	0.000806	CbGbCtD
Valproic Acid—SLC16A1—lung—hematologic cancer	0.000318	0.0089	CbGeAlD
Valproic Acid—CYP2A6—lung—hematologic cancer	0.000313	0.00877	CbGeAlD
Valproic Acid—CYP2C8—hematopoietic system—hematologic cancer	0.000303	0.00848	CbGeAlD
Valproic Acid—SLC16A1—testis—hematologic cancer	0.0003	0.0084	CbGeAlD
Valproic Acid—CYP1A2—hematopoietic system—hematologic cancer	0.000283	0.00794	CbGeAlD
Valproic Acid—SLC22A8—blood—hematologic cancer	0.000274	0.00768	CbGeAlD
Valproic Acid—CYP3A5—hematopoietic system—hematologic cancer	0.000273	0.00765	CbGeAlD
Valproic Acid—CYP2B6—hematopoietic system—hematologic cancer	0.000272	0.00761	CbGeAlD
Valproic Acid—CYP2C9—hematopoietic system—hematologic cancer	0.000269	0.00753	CbGeAlD
Valproic Acid—PTGS1—hematopoietic system—hematologic cancer	0.000246	0.00688	CbGeAlD
Valproic Acid—HDAC2—lymph node—hematologic cancer	0.000245	0.00685	CbGeAlD
Valproic Acid—CYP2C19—blood—hematologic cancer	0.00023	0.00644	CbGeAlD
Valproic Acid—SLC16A1—lymph node—hematologic cancer	0.000217	0.00609	CbGeAlD
Valproic Acid—SLC22A5—blood—hematologic cancer	0.000207	0.0058	CbGeAlD
Valproic Acid—CYP2B6—gonad—hematologic cancer	0.000207	0.00578	CbGeAlD
Valproic Acid—CYP3A4—hematopoietic system—hematologic cancer	0.000205	0.00574	CbGeAlD
Valproic Acid—CYP2C8—blood—hematologic cancer	0.000201	0.00562	CbGeAlD
Valproic Acid—HDAC2—Menadione—Thalidomide—hematologic cancer	0.0002	0.123	CbGdCrCtD
Valproic Acid—CYP1A2—blood—hematologic cancer	0.000188	0.00526	CbGeAlD
Valproic Acid—SLC22A5—lung—hematologic cancer	0.000182	0.00509	CbGeAlD
Valproic Acid—CYP3A5—blood—hematologic cancer	0.000181	0.00507	CbGeAlD
Valproic Acid—CYP2B6—blood—hematologic cancer	0.00018	0.00504	CbGeAlD
Valproic Acid—CYP2C9—blood—hematologic cancer	0.000178	0.00499	CbGeAlD
Valproic Acid—SLC22A5—testis—hematologic cancer	0.000171	0.0048	CbGeAlD
Valproic Acid—CYP2C8—testis—hematologic cancer	0.000166	0.00465	CbGeAlD
Valproic Acid—CYP1A2—lung—hematologic cancer	0.000165	0.00461	CbGeAlD
Valproic Acid—PTGS1—blood—hematologic cancer	0.000163	0.00456	CbGeAlD
Valproic Acid—CYP3A5—lung—hematologic cancer	0.000159	0.00445	CbGeAlD
Valproic Acid—CYP2B6—lung—hematologic cancer	0.000158	0.00442	CbGeAlD
Valproic Acid—HDAC2—Teniposide—Etoposide—hematologic cancer	0.000157	0.0964	CbGdCrCtD
Valproic Acid—CYP2B6—testis—hematologic cancer	0.000149	0.00417	CbGeAlD
Valproic Acid—PTGS1—lung—hematologic cancer	0.000143	0.00399	CbGeAlD
Valproic Acid—CYP3A4—blood—hematologic cancer	0.000136	0.00381	CbGeAlD
Valproic Acid—PTGS1—testis—hematologic cancer	0.000135	0.00377	CbGeAlD
Valproic Acid—SLC22A5—lymph node—hematologic cancer	0.000124	0.00348	CbGeAlD
Valproic Acid—PTGS1—lymph node—hematologic cancer	9.75e-05	0.00273	CbGeAlD
Valproic Acid—Dermatitis—Cisplatin—hematologic cancer	8.04e-06	5.57e-05	CcSEcCtD
Valproic Acid—Malnutrition—Epirubicin—hematologic cancer	8.03e-06	5.56e-05	CcSEcCtD
Valproic Acid—Diarrhoea—Etoposide—hematologic cancer	8e-06	5.54e-05	CcSEcCtD
Valproic Acid—Anorexia—Prednisone—hematologic cancer	7.99e-06	5.53e-05	CcSEcCtD
Valproic Acid—Eye disorder—Doxorubicin—hematologic cancer	7.98e-06	5.53e-05	CcSEcCtD
Valproic Acid—Ill-defined disorder—Methotrexate—hematologic cancer	7.96e-06	5.52e-05	CcSEcCtD
Valproic Acid—Tinnitus—Doxorubicin—hematologic cancer	7.96e-06	5.51e-05	CcSEcCtD
Valproic Acid—Anaemia—Methotrexate—hematologic cancer	7.93e-06	5.49e-05	CcSEcCtD
Valproic Acid—Feeling abnormal—Dexamethasone—hematologic cancer	7.93e-06	5.49e-05	CcSEcCtD
Valproic Acid—Feeling abnormal—Betamethasone—hematologic cancer	7.93e-06	5.49e-05	CcSEcCtD
Valproic Acid—Flatulence—Epirubicin—hematologic cancer	7.92e-06	5.48e-05	CcSEcCtD
Valproic Acid—Tension—Epirubicin—hematologic cancer	7.88e-06	5.46e-05	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.87e-06	5.45e-05	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Betamethasone—hematologic cancer	7.87e-06	5.45e-05	CcSEcCtD
Valproic Acid—Dysgeusia—Epirubicin—hematologic cancer	7.87e-06	5.45e-05	CcSEcCtD
Valproic Acid—Hypersensitivity—Triamcinolone—hematologic cancer	7.82e-06	5.41e-05	CcSEcCtD
Valproic Acid—Nervousness—Epirubicin—hematologic cancer	7.8e-06	5.4e-05	CcSEcCtD
Valproic Acid—Back pain—Epirubicin—hematologic cancer	7.77e-06	5.38e-05	CcSEcCtD
Valproic Acid—Angiopathy—Doxorubicin—hematologic cancer	7.75e-06	5.36e-05	CcSEcCtD
Valproic Acid—Malaise—Methotrexate—hematologic cancer	7.74e-06	5.36e-05	CcSEcCtD
Valproic Acid—Dizziness—Etoposide—hematologic cancer	7.73e-06	5.36e-05	CcSEcCtD
Valproic Acid—Muscle spasms—Epirubicin—hematologic cancer	7.72e-06	5.35e-05	CcSEcCtD
Valproic Acid—Immune system disorder—Doxorubicin—hematologic cancer	7.71e-06	5.34e-05	CcSEcCtD
Valproic Acid—Vertigo—Methotrexate—hematologic cancer	7.71e-06	5.34e-05	CcSEcCtD
Valproic Acid—Mediastinal disorder—Doxorubicin—hematologic cancer	7.7e-06	5.33e-05	CcSEcCtD
Valproic Acid—Leukopenia—Methotrexate—hematologic cancer	7.68e-06	5.32e-05	CcSEcCtD
Valproic Acid—Chills—Doxorubicin—hematologic cancer	7.66e-06	5.31e-05	CcSEcCtD
Valproic Acid—Urticaria—Dexamethasone—hematologic cancer	7.65e-06	5.3e-05	CcSEcCtD
Valproic Acid—Urticaria—Betamethasone—hematologic cancer	7.65e-06	5.3e-05	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Prednisone—hematologic cancer	7.64e-06	5.29e-05	CcSEcCtD
Valproic Acid—Dizziness—Prednisolone—hematologic cancer	7.63e-06	5.28e-05	CcSEcCtD
Valproic Acid—Arrhythmia—Doxorubicin—hematologic cancer	7.63e-06	5.28e-05	CcSEcCtD
Valproic Acid—Asthenia—Triamcinolone—hematologic cancer	7.61e-06	5.27e-05	CcSEcCtD
Valproic Acid—Abdominal pain—Betamethasone—hematologic cancer	7.61e-06	5.27e-05	CcSEcCtD
Valproic Acid—Body temperature increased—Betamethasone—hematologic cancer	7.61e-06	5.27e-05	CcSEcCtD
Valproic Acid—Abdominal pain—Dexamethasone—hematologic cancer	7.61e-06	5.27e-05	CcSEcCtD
Valproic Acid—Body temperature increased—Dexamethasone—hematologic cancer	7.61e-06	5.27e-05	CcSEcCtD
Valproic Acid—Nausea—Cisplatin—hematologic cancer	7.58e-06	5.25e-05	CcSEcCtD
Valproic Acid—Insomnia—Prednisone—hematologic cancer	7.58e-06	5.25e-05	CcSEcCtD
Valproic Acid—Vision blurred—Epirubicin—hematologic cancer	7.57e-06	5.24e-05	CcSEcCtD
Valproic Acid—Alopecia—Doxorubicin—hematologic cancer	7.55e-06	5.22e-05	CcSEcCtD
Valproic Acid—Paraesthesia—Prednisone—hematologic cancer	7.53e-06	5.21e-05	CcSEcCtD
Valproic Acid—Pruritus—Triamcinolone—hematologic cancer	7.51e-06	5.2e-05	CcSEcCtD
Valproic Acid—Cough—Methotrexate—hematologic cancer	7.49e-06	5.19e-05	CcSEcCtD
Valproic Acid—Mental disorder—Doxorubicin—hematologic cancer	7.48e-06	5.18e-05	CcSEcCtD
Valproic Acid—Ill-defined disorder—Epirubicin—hematologic cancer	7.45e-06	5.16e-05	CcSEcCtD
Valproic Acid—Vomiting—Etoposide—hematologic cancer	7.44e-06	5.15e-05	CcSEcCtD
Valproic Acid—Malnutrition—Doxorubicin—hematologic cancer	7.43e-06	5.15e-05	CcSEcCtD
Valproic Acid—Anaemia—Epirubicin—hematologic cancer	7.42e-06	5.14e-05	CcSEcCtD
Valproic Acid—Agitation—Epirubicin—hematologic cancer	7.38e-06	5.11e-05	CcSEcCtD
Valproic Acid—Dyspepsia—Prednisone—hematologic cancer	7.38e-06	5.11e-05	CcSEcCtD
Valproic Acid—Rash—Etoposide—hematologic cancer	7.37e-06	5.11e-05	CcSEcCtD
Valproic Acid—Dermatitis—Etoposide—hematologic cancer	7.37e-06	5.1e-05	CcSEcCtD
Valproic Acid—Headache—Etoposide—hematologic cancer	7.33e-06	5.07e-05	CcSEcCtD
Valproic Acid—Flatulence—Doxorubicin—hematologic cancer	7.32e-06	5.07e-05	CcSEcCtD
Valproic Acid—Chest pain—Methotrexate—hematologic cancer	7.31e-06	5.06e-05	CcSEcCtD
Valproic Acid—Arthralgia—Methotrexate—hematologic cancer	7.31e-06	5.06e-05	CcSEcCtD
Valproic Acid—Myalgia—Methotrexate—hematologic cancer	7.31e-06	5.06e-05	CcSEcCtD
Valproic Acid—Tension—Doxorubicin—hematologic cancer	7.29e-06	5.05e-05	CcSEcCtD
Valproic Acid—Decreased appetite—Prednisone—hematologic cancer	7.29e-06	5.05e-05	CcSEcCtD
Valproic Acid—Dysgeusia—Doxorubicin—hematologic cancer	7.28e-06	5.04e-05	CcSEcCtD
Valproic Acid—Rash—Prednisolone—hematologic cancer	7.27e-06	5.04e-05	CcSEcCtD
Valproic Acid—Dermatitis—Prednisolone—hematologic cancer	7.27e-06	5.03e-05	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	7.26e-06	5.03e-05	CcSEcCtD
Valproic Acid—Malaise—Epirubicin—hematologic cancer	7.24e-06	5.02e-05	CcSEcCtD
Valproic Acid—Fatigue—Prednisone—hematologic cancer	7.23e-06	5e-05	CcSEcCtD
Valproic Acid—Headache—Prednisolone—hematologic cancer	7.23e-06	5e-05	CcSEcCtD
Valproic Acid—Discomfort—Methotrexate—hematologic cancer	7.22e-06	5e-05	CcSEcCtD
Valproic Acid—Nervousness—Doxorubicin—hematologic cancer	7.22e-06	5e-05	CcSEcCtD
Valproic Acid—Vertigo—Epirubicin—hematologic cancer	7.22e-06	5e-05	CcSEcCtD
Valproic Acid—Leukopenia—Epirubicin—hematologic cancer	7.19e-06	4.98e-05	CcSEcCtD
Valproic Acid—Back pain—Doxorubicin—hematologic cancer	7.19e-06	4.98e-05	CcSEcCtD
Valproic Acid—Constipation—Prednisone—hematologic cancer	7.17e-06	4.96e-05	CcSEcCtD
Valproic Acid—Muscle spasms—Doxorubicin—hematologic cancer	7.15e-06	4.95e-05	CcSEcCtD
Valproic Acid—Palpitations—Epirubicin—hematologic cancer	7.1e-06	4.92e-05	CcSEcCtD
Valproic Acid—Confusional state—Methotrexate—hematologic cancer	7.06e-06	4.89e-05	CcSEcCtD
Valproic Acid—Dizziness—Triamcinolone—hematologic cancer	7.02e-06	4.86e-05	CcSEcCtD
Valproic Acid—Cough—Epirubicin—hematologic cancer	7.01e-06	4.85e-05	CcSEcCtD
Valproic Acid—Anaphylactic shock—Methotrexate—hematologic cancer	7.01e-06	4.85e-05	CcSEcCtD
Valproic Acid—Vision blurred—Doxorubicin—hematologic cancer	7.01e-06	4.85e-05	CcSEcCtD
Valproic Acid—Infection—Methotrexate—hematologic cancer	6.96e-06	4.82e-05	CcSEcCtD
Valproic Acid—Nausea—Etoposide—hematologic cancer	6.95e-06	4.81e-05	CcSEcCtD
Valproic Acid—Hypertension—Epirubicin—hematologic cancer	6.94e-06	4.8e-05	CcSEcCtD
Valproic Acid—Feeling abnormal—Prednisone—hematologic cancer	6.91e-06	4.78e-05	CcSEcCtD
Valproic Acid—Asthenia—Dexamethasone—hematologic cancer	6.91e-06	4.78e-05	CcSEcCtD
Valproic Acid—Asthenia—Betamethasone—hematologic cancer	6.91e-06	4.78e-05	CcSEcCtD
Valproic Acid—Ill-defined disorder—Doxorubicin—hematologic cancer	6.9e-06	4.78e-05	CcSEcCtD
Valproic Acid—Nervous system disorder—Methotrexate—hematologic cancer	6.87e-06	4.76e-05	CcSEcCtD
Valproic Acid—Anaemia—Doxorubicin—hematologic cancer	6.87e-06	4.76e-05	CcSEcCtD
Valproic Acid—Thrombocytopenia—Methotrexate—hematologic cancer	6.86e-06	4.75e-05	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Prednisone—hematologic cancer	6.85e-06	4.75e-05	CcSEcCtD
Valproic Acid—Nausea—Prednisolone—hematologic cancer	6.85e-06	4.74e-05	CcSEcCtD
Valproic Acid—Myalgia—Epirubicin—hematologic cancer	6.84e-06	4.74e-05	CcSEcCtD
Valproic Acid—Chest pain—Epirubicin—hematologic cancer	6.84e-06	4.74e-05	CcSEcCtD
Valproic Acid—Arthralgia—Epirubicin—hematologic cancer	6.84e-06	4.74e-05	CcSEcCtD
Valproic Acid—Agitation—Doxorubicin—hematologic cancer	6.83e-06	4.73e-05	CcSEcCtD
Valproic Acid—Anxiety—Epirubicin—hematologic cancer	6.82e-06	4.72e-05	CcSEcCtD
Valproic Acid—Pruritus—Betamethasone—hematologic cancer	6.81e-06	4.72e-05	CcSEcCtD
Valproic Acid—Pruritus—Dexamethasone—hematologic cancer	6.81e-06	4.72e-05	CcSEcCtD
Valproic Acid—Skin disorder—Methotrexate—hematologic cancer	6.8e-06	4.71e-05	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	6.79e-06	4.7e-05	CcSEcCtD
Valproic Acid—Hyperhidrosis—Methotrexate—hematologic cancer	6.77e-06	4.69e-05	CcSEcCtD
Valproic Acid—Discomfort—Epirubicin—hematologic cancer	6.76e-06	4.68e-05	CcSEcCtD
Valproic Acid—Vomiting—Triamcinolone—hematologic cancer	6.75e-06	4.67e-05	CcSEcCtD
Valproic Acid—Malaise—Doxorubicin—hematologic cancer	6.7e-06	4.64e-05	CcSEcCtD
Valproic Acid—Rash—Triamcinolone—hematologic cancer	6.69e-06	4.63e-05	CcSEcCtD
Valproic Acid—Dry mouth—Epirubicin—hematologic cancer	6.69e-06	4.63e-05	CcSEcCtD
Valproic Acid—Dermatitis—Triamcinolone—hematologic cancer	6.68e-06	4.63e-05	CcSEcCtD
Valproic Acid—Vertigo—Doxorubicin—hematologic cancer	6.68e-06	4.62e-05	CcSEcCtD
Valproic Acid—Anorexia—Methotrexate—hematologic cancer	6.68e-06	4.62e-05	CcSEcCtD
Valproic Acid—Urticaria—Prednisone—hematologic cancer	6.66e-06	4.61e-05	CcSEcCtD
Valproic Acid—Leukopenia—Doxorubicin—hematologic cancer	6.65e-06	4.61e-05	CcSEcCtD
Valproic Acid—Headache—Triamcinolone—hematologic cancer	6.65e-06	4.6e-05	CcSEcCtD
Valproic Acid—Body temperature increased—Prednisone—hematologic cancer	6.63e-06	4.59e-05	CcSEcCtD
Valproic Acid—Abdominal pain—Prednisone—hematologic cancer	6.63e-06	4.59e-05	CcSEcCtD
Valproic Acid—Confusional state—Epirubicin—hematologic cancer	6.61e-06	4.58e-05	CcSEcCtD
Valproic Acid—Diarrhoea—Betamethasone—hematologic cancer	6.59e-06	4.56e-05	CcSEcCtD
Valproic Acid—Diarrhoea—Dexamethasone—hematologic cancer	6.59e-06	4.56e-05	CcSEcCtD
Valproic Acid—Palpitations—Doxorubicin—hematologic cancer	6.57e-06	4.55e-05	CcSEcCtD
Valproic Acid—Anaphylactic shock—Epirubicin—hematologic cancer	6.56e-06	4.54e-05	CcSEcCtD
Valproic Acid—Oedema—Epirubicin—hematologic cancer	6.56e-06	4.54e-05	CcSEcCtD
Valproic Acid—Hypotension—Methotrexate—hematologic cancer	6.55e-06	4.53e-05	CcSEcCtD
Valproic Acid—Infection—Epirubicin—hematologic cancer	6.51e-06	4.51e-05	CcSEcCtD
Valproic Acid—Cough—Doxorubicin—hematologic cancer	6.49e-06	4.49e-05	CcSEcCtD
Valproic Acid—Nervous system disorder—Epirubicin—hematologic cancer	6.43e-06	4.45e-05	CcSEcCtD
Valproic Acid—Thrombocytopenia—Epirubicin—hematologic cancer	6.42e-06	4.45e-05	CcSEcCtD
Valproic Acid—Hypertension—Doxorubicin—hematologic cancer	6.42e-06	4.44e-05	CcSEcCtD
Valproic Acid—Tachycardia—Epirubicin—hematologic cancer	6.4e-06	4.43e-05	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Methotrexate—hematologic cancer	6.38e-06	4.42e-05	CcSEcCtD
Valproic Acid—Skin disorder—Epirubicin—hematologic cancer	6.37e-06	4.41e-05	CcSEcCtD
Valproic Acid—Dizziness—Betamethasone—hematologic cancer	6.37e-06	4.41e-05	CcSEcCtD
Valproic Acid—Dizziness—Dexamethasone—hematologic cancer	6.37e-06	4.41e-05	CcSEcCtD
Valproic Acid—Hyperhidrosis—Epirubicin—hematologic cancer	6.34e-06	4.39e-05	CcSEcCtD
Valproic Acid—Insomnia—Methotrexate—hematologic cancer	6.34e-06	4.39e-05	CcSEcCtD
Valproic Acid—Myalgia—Doxorubicin—hematologic cancer	6.33e-06	4.38e-05	CcSEcCtD
Valproic Acid—Arthralgia—Doxorubicin—hematologic cancer	6.33e-06	4.38e-05	CcSEcCtD
Valproic Acid—Chest pain—Doxorubicin—hematologic cancer	6.33e-06	4.38e-05	CcSEcCtD
Valproic Acid—Anxiety—Doxorubicin—hematologic cancer	6.31e-06	4.37e-05	CcSEcCtD
Valproic Acid—Nausea—Triamcinolone—hematologic cancer	6.3e-06	4.36e-05	CcSEcCtD
Valproic Acid—Paraesthesia—Methotrexate—hematologic cancer	6.29e-06	4.36e-05	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	6.28e-06	4.35e-05	CcSEcCtD
Valproic Acid—Discomfort—Doxorubicin—hematologic cancer	6.25e-06	4.33e-05	CcSEcCtD
Valproic Acid—Anorexia—Epirubicin—hematologic cancer	6.25e-06	4.33e-05	CcSEcCtD
Valproic Acid—Dyspnoea—Methotrexate—hematologic cancer	6.25e-06	4.33e-05	CcSEcCtD
Valproic Acid—Somnolence—Methotrexate—hematologic cancer	6.23e-06	4.31e-05	CcSEcCtD
Valproic Acid—Dry mouth—Doxorubicin—hematologic cancer	6.19e-06	4.29e-05	CcSEcCtD
Valproic Acid—Hypersensitivity—Prednisone—hematologic cancer	6.18e-06	4.28e-05	CcSEcCtD
Valproic Acid—Dyspepsia—Methotrexate—hematologic cancer	6.17e-06	4.27e-05	CcSEcCtD
Valproic Acid—Hypotension—Epirubicin—hematologic cancer	6.13e-06	4.24e-05	CcSEcCtD
Valproic Acid—Vomiting—Dexamethasone—hematologic cancer	6.12e-06	4.24e-05	CcSEcCtD
Valproic Acid—Vomiting—Betamethasone—hematologic cancer	6.12e-06	4.24e-05	CcSEcCtD
Valproic Acid—Confusional state—Doxorubicin—hematologic cancer	6.12e-06	4.24e-05	CcSEcCtD
Valproic Acid—Decreased appetite—Methotrexate—hematologic cancer	6.09e-06	4.22e-05	CcSEcCtD
Valproic Acid—Rash—Dexamethasone—hematologic cancer	6.07e-06	4.2e-05	CcSEcCtD
Valproic Acid—Rash—Betamethasone—hematologic cancer	6.07e-06	4.2e-05	CcSEcCtD
Valproic Acid—Oedema—Doxorubicin—hematologic cancer	6.07e-06	4.2e-05	CcSEcCtD
Valproic Acid—Anaphylactic shock—Doxorubicin—hematologic cancer	6.07e-06	4.2e-05	CcSEcCtD
Valproic Acid—Dermatitis—Betamethasone—hematologic cancer	6.06e-06	4.2e-05	CcSEcCtD
Valproic Acid—Dermatitis—Dexamethasone—hematologic cancer	6.06e-06	4.2e-05	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.05e-06	4.19e-05	CcSEcCtD
Valproic Acid—Fatigue—Methotrexate—hematologic cancer	6.04e-06	4.18e-05	CcSEcCtD
Valproic Acid—Headache—Dexamethasone—hematologic cancer	6.03e-06	4.18e-05	CcSEcCtD
Valproic Acid—Headache—Betamethasone—hematologic cancer	6.03e-06	4.18e-05	CcSEcCtD
Valproic Acid—Infection—Doxorubicin—hematologic cancer	6.03e-06	4.17e-05	CcSEcCtD
Valproic Acid—Asthenia—Prednisone—hematologic cancer	6.01e-06	4.16e-05	CcSEcCtD
Valproic Acid—Pain—Methotrexate—hematologic cancer	5.99e-06	4.15e-05	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.97e-06	4.14e-05	CcSEcCtD
Valproic Acid—Nervous system disorder—Doxorubicin—hematologic cancer	5.95e-06	4.12e-05	CcSEcCtD
Valproic Acid—Thrombocytopenia—Doxorubicin—hematologic cancer	5.94e-06	4.11e-05	CcSEcCtD
Valproic Acid—Pruritus—Prednisone—hematologic cancer	5.93e-06	4.11e-05	CcSEcCtD
Valproic Acid—Insomnia—Epirubicin—hematologic cancer	5.93e-06	4.11e-05	CcSEcCtD
Valproic Acid—Tachycardia—Doxorubicin—hematologic cancer	5.92e-06	4.1e-05	CcSEcCtD
Valproic Acid—Skin disorder—Doxorubicin—hematologic cancer	5.89e-06	4.08e-05	CcSEcCtD
Valproic Acid—Paraesthesia—Epirubicin—hematologic cancer	5.89e-06	4.08e-05	CcSEcCtD
Valproic Acid—Hyperhidrosis—Doxorubicin—hematologic cancer	5.86e-06	4.06e-05	CcSEcCtD
Valproic Acid—Dyspnoea—Epirubicin—hematologic cancer	5.85e-06	4.05e-05	CcSEcCtD
Valproic Acid—Somnolence—Epirubicin—hematologic cancer	5.83e-06	4.04e-05	CcSEcCtD
Valproic Acid—Anorexia—Doxorubicin—hematologic cancer	5.78e-06	4e-05	CcSEcCtD
Valproic Acid—Feeling abnormal—Methotrexate—hematologic cancer	5.77e-06	4e-05	CcSEcCtD
Valproic Acid—Dyspepsia—Epirubicin—hematologic cancer	5.77e-06	4e-05	CcSEcCtD
Valproic Acid—Diarrhoea—Prednisone—hematologic cancer	5.74e-06	3.97e-05	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Methotrexate—hematologic cancer	5.73e-06	3.97e-05	CcSEcCtD
Valproic Acid—Nausea—Betamethasone—hematologic cancer	5.72e-06	3.96e-05	CcSEcCtD
Valproic Acid—Nausea—Dexamethasone—hematologic cancer	5.72e-06	3.96e-05	CcSEcCtD
Valproic Acid—Decreased appetite—Epirubicin—hematologic cancer	5.7e-06	3.95e-05	CcSEcCtD
Valproic Acid—Hypotension—Doxorubicin—hematologic cancer	5.67e-06	3.93e-05	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.66e-06	3.92e-05	CcSEcCtD
Valproic Acid—Fatigue—Epirubicin—hematologic cancer	5.65e-06	3.91e-05	CcSEcCtD
Valproic Acid—Constipation—Epirubicin—hematologic cancer	5.61e-06	3.88e-05	CcSEcCtD
Valproic Acid—Pain—Epirubicin—hematologic cancer	5.61e-06	3.88e-05	CcSEcCtD
Valproic Acid—Urticaria—Methotrexate—hematologic cancer	5.57e-06	3.85e-05	CcSEcCtD
Valproic Acid—Dizziness—Prednisone—hematologic cancer	5.54e-06	3.84e-05	CcSEcCtD
Valproic Acid—Body temperature increased—Methotrexate—hematologic cancer	5.54e-06	3.83e-05	CcSEcCtD
Valproic Acid—Abdominal pain—Methotrexate—hematologic cancer	5.54e-06	3.83e-05	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.53e-06	3.83e-05	CcSEcCtD
Valproic Acid—Insomnia—Doxorubicin—hematologic cancer	5.49e-06	3.8e-05	CcSEcCtD
Valproic Acid—Paraesthesia—Doxorubicin—hematologic cancer	5.45e-06	3.77e-05	CcSEcCtD
Valproic Acid—Dyspnoea—Doxorubicin—hematologic cancer	5.41e-06	3.75e-05	CcSEcCtD
Valproic Acid—Feeling abnormal—Epirubicin—hematologic cancer	5.4e-06	3.74e-05	CcSEcCtD
Valproic Acid—Somnolence—Doxorubicin—hematologic cancer	5.39e-06	3.73e-05	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Epirubicin—hematologic cancer	5.36e-06	3.71e-05	CcSEcCtD
Valproic Acid—Dyspepsia—Doxorubicin—hematologic cancer	5.34e-06	3.7e-05	CcSEcCtD
Valproic Acid—Vomiting—Prednisone—hematologic cancer	5.33e-06	3.69e-05	CcSEcCtD
Valproic Acid—Rash—Prednisone—hematologic cancer	5.29e-06	3.66e-05	CcSEcCtD
Valproic Acid—Dermatitis—Prednisone—hematologic cancer	5.28e-06	3.66e-05	CcSEcCtD
Valproic Acid—Decreased appetite—Doxorubicin—hematologic cancer	5.27e-06	3.65e-05	CcSEcCtD
Valproic Acid—Headache—Prednisone—hematologic cancer	5.25e-06	3.64e-05	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.24e-06	3.63e-05	CcSEcCtD
Valproic Acid—Fatigue—Doxorubicin—hematologic cancer	5.23e-06	3.62e-05	CcSEcCtD
Valproic Acid—Urticaria—Epirubicin—hematologic cancer	5.21e-06	3.61e-05	CcSEcCtD
Valproic Acid—Pain—Doxorubicin—hematologic cancer	5.19e-06	3.59e-05	CcSEcCtD
Valproic Acid—Constipation—Doxorubicin—hematologic cancer	5.19e-06	3.59e-05	CcSEcCtD
Valproic Acid—Abdominal pain—Epirubicin—hematologic cancer	5.18e-06	3.59e-05	CcSEcCtD
Valproic Acid—Body temperature increased—Epirubicin—hematologic cancer	5.18e-06	3.59e-05	CcSEcCtD
Valproic Acid—Hypersensitivity—Methotrexate—hematologic cancer	5.16e-06	3.57e-05	CcSEcCtD
Valproic Acid—Asthenia—Methotrexate—hematologic cancer	5.03e-06	3.48e-05	CcSEcCtD
Valproic Acid—Feeling abnormal—Doxorubicin—hematologic cancer	5e-06	3.46e-05	CcSEcCtD
Valproic Acid—Nausea—Prednisone—hematologic cancer	4.98e-06	3.45e-05	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.96e-06	3.44e-05	CcSEcCtD
Valproic Acid—Pruritus—Methotrexate—hematologic cancer	4.96e-06	3.43e-05	CcSEcCtD
Valproic Acid—Hypersensitivity—Epirubicin—hematologic cancer	4.83e-06	3.34e-05	CcSEcCtD
Valproic Acid—Urticaria—Doxorubicin—hematologic cancer	4.82e-06	3.34e-05	CcSEcCtD
Valproic Acid—Abdominal pain—Doxorubicin—hematologic cancer	4.8e-06	3.32e-05	CcSEcCtD
Valproic Acid—Body temperature increased—Doxorubicin—hematologic cancer	4.8e-06	3.32e-05	CcSEcCtD
Valproic Acid—Diarrhoea—Methotrexate—hematologic cancer	4.79e-06	3.32e-05	CcSEcCtD
Valproic Acid—Asthenia—Epirubicin—hematologic cancer	4.7e-06	3.26e-05	CcSEcCtD
Valproic Acid—Pruritus—Epirubicin—hematologic cancer	4.64e-06	3.21e-05	CcSEcCtD
Valproic Acid—Dizziness—Methotrexate—hematologic cancer	4.63e-06	3.21e-05	CcSEcCtD
Valproic Acid—Diarrhoea—Epirubicin—hematologic cancer	4.49e-06	3.11e-05	CcSEcCtD
Valproic Acid—Hypersensitivity—Doxorubicin—hematologic cancer	4.47e-06	3.09e-05	CcSEcCtD
Valproic Acid—Vomiting—Methotrexate—hematologic cancer	4.45e-06	3.08e-05	CcSEcCtD
Valproic Acid—Rash—Methotrexate—hematologic cancer	4.42e-06	3.06e-05	CcSEcCtD
Valproic Acid—Dermatitis—Methotrexate—hematologic cancer	4.41e-06	3.06e-05	CcSEcCtD
Valproic Acid—Headache—Methotrexate—hematologic cancer	4.39e-06	3.04e-05	CcSEcCtD
Valproic Acid—Asthenia—Doxorubicin—hematologic cancer	4.35e-06	3.01e-05	CcSEcCtD
Valproic Acid—Dizziness—Epirubicin—hematologic cancer	4.34e-06	3e-05	CcSEcCtD
Valproic Acid—Pruritus—Doxorubicin—hematologic cancer	4.29e-06	2.97e-05	CcSEcCtD
Valproic Acid—Vomiting—Epirubicin—hematologic cancer	4.17e-06	2.89e-05	CcSEcCtD
Valproic Acid—Nausea—Methotrexate—hematologic cancer	4.16e-06	2.88e-05	CcSEcCtD
Valproic Acid—Diarrhoea—Doxorubicin—hematologic cancer	4.15e-06	2.87e-05	CcSEcCtD
Valproic Acid—Rash—Epirubicin—hematologic cancer	4.13e-06	2.86e-05	CcSEcCtD
Valproic Acid—Dermatitis—Epirubicin—hematologic cancer	4.13e-06	2.86e-05	CcSEcCtD
Valproic Acid—Headache—Epirubicin—hematologic cancer	4.11e-06	2.84e-05	CcSEcCtD
Valproic Acid—Dizziness—Doxorubicin—hematologic cancer	4.01e-06	2.78e-05	CcSEcCtD
Valproic Acid—Nausea—Epirubicin—hematologic cancer	3.89e-06	2.7e-05	CcSEcCtD
Valproic Acid—Vomiting—Doxorubicin—hematologic cancer	3.86e-06	2.67e-05	CcSEcCtD
Valproic Acid—Rash—Doxorubicin—hematologic cancer	3.82e-06	2.65e-05	CcSEcCtD
Valproic Acid—Dermatitis—Doxorubicin—hematologic cancer	3.82e-06	2.65e-05	CcSEcCtD
Valproic Acid—Headache—Doxorubicin—hematologic cancer	3.8e-06	2.63e-05	CcSEcCtD
Valproic Acid—Nausea—Doxorubicin—hematologic cancer	3.6e-06	2.5e-05	CcSEcCtD
Valproic Acid—CYP1A2—Metabolism—ALOX5—hematologic cancer	1.18e-06	1.47e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SDC1—hematologic cancer	1.17e-06	1.46e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CD—hematologic cancer	1.16e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.16e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYCS—hematologic cancer	1.16e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	1.15e-06	1.44e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ALB—hematologic cancer	1.15e-06	1.43e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ABCB1—hematologic cancer	1.14e-06	1.42e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NUP98—hematologic cancer	1.14e-06	1.42e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KRAS—hematologic cancer	1.14e-06	1.42e-05	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—AKT1—hematologic cancer	1.14e-06	1.42e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.13e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDKN1B—hematologic cancer	1.13e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.13e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.12e-06	1.4e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ABCB1—hematologic cancer	1.12e-06	1.39e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTEN—hematologic cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—NCOR1—hematologic cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GSTM1—hematologic cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ADCY7—hematologic cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NCOA3—hematologic cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CASP3—hematologic cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL2—hematologic cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NUP214—hematologic cancer	1.1e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3R1—hematologic cancer	1.1e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CA9—hematologic cancer	1.1e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ACP5—hematologic cancer	1.1e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NQO1—hematologic cancer	1.09e-06	1.36e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CD44—hematologic cancer	1.09e-06	1.36e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.09e-06	1.36e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—NCOR1—hematologic cancer	1.08e-06	1.35e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GSTM1—hematologic cancer	1.08e-06	1.35e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.08e-06	1.35e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CG—hematologic cancer	1.08e-06	1.35e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTEN—hematologic cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCND1—hematologic cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ABCG2—hematologic cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—MTR—hematologic cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PIK3CA—hematologic cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—JUN—hematologic cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.07e-06	1.33e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—EP300—hematologic cancer	1.06e-06	1.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.06e-06	1.32e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ENO2—hematologic cancer	1.06e-06	1.32e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PIK3CA—hematologic cancer	1.05e-06	1.31e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDKN1A—hematologic cancer	1.04e-06	1.3e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTEN—hematologic cancer	1.04e-06	1.3e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.04e-06	1.29e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYCS—hematologic cancer	1.04e-06	1.29e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—IDH1—hematologic cancer	1.03e-06	1.29e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—EP300—hematologic cancer	1.03e-06	1.28e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	1.03e-06	1.28e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTT1—hematologic cancer	1.03e-06	1.28e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTP1—hematologic cancer	1.02e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CG—hematologic cancer	1.02e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—TXN—hematologic cancer	1.02e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.02e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.02e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK8—hematologic cancer	1.02e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CB—hematologic cancer	1.02e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.01e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SDC1—hematologic cancer	1e-06	1.25e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CREBBP—hematologic cancer	1e-06	1.25e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SPHK1—hematologic cancer	9.99e-07	1.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CD44—hematologic cancer	9.98e-07	1.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NQO1—hematologic cancer	9.98e-07	1.24e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EP300—hematologic cancer	9.93e-07	1.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	9.89e-07	1.23e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—MTHFR—hematologic cancer	9.81e-07	1.22e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.77e-07	1.22e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—hematologic cancer	9.7e-07	1.21e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ABCB1—hematologic cancer	9.68e-07	1.21e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SRC—hematologic cancer	9.65e-07	1.2e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PIK3CA—hematologic cancer	9.6e-07	1.2e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—UGT1A1—hematologic cancer	9.6e-07	1.2e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—MTHFR—hematologic cancer	9.59e-07	1.19e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.58e-07	1.19e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CD—hematologic cancer	9.49e-07	1.18e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CREBBP—hematologic cancer	9.47e-07	1.18e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	9.45e-07	1.18e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYCS—hematologic cancer	9.44e-07	1.18e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—hematologic cancer	9.4e-07	1.17e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—NCOR1—hematologic cancer	9.39e-07	1.17e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTM1—hematologic cancer	9.39e-07	1.17e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	9.38e-07	1.17e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ALB—hematologic cancer	9.37e-07	1.17e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CRABP1—hematologic cancer	9.34e-07	1.16e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC22A1—hematologic cancer	9.34e-07	1.16e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STAT3—hematologic cancer	9.31e-07	1.16e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRAS—hematologic cancer	9.29e-07	1.16e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—hematologic cancer	9.29e-07	1.16e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.26e-07	1.15e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—hematologic cancer	9.23e-07	1.15e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTP1—hematologic cancer	9.12e-07	1.14e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALOX5—hematologic cancer	9.1e-07	1.13e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.04e-07	1.13e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CD—hematologic cancer	8.98e-07	1.12e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3R1—hematologic cancer	8.96e-07	1.12e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CA—hematologic cancer	8.96e-07	1.12e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK3—hematologic cancer	8.89e-07	1.11e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ALB—hematologic cancer	8.86e-07	1.1e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.83e-07	1.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NUP98—hematologic cancer	8.81e-07	1.1e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—hematologic cancer	8.8e-07	1.1e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTEN—hematologic cancer	8.77e-07	1.09e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—hematologic cancer	8.65e-07	1.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ABCB1—hematologic cancer	8.64e-07	1.08e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFB1—hematologic cancer	8.63e-07	1.08e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—hematologic cancer	8.57e-07	1.07e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ADCY7—hematologic cancer	8.56e-07	1.07e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NCOA3—hematologic cancer	8.56e-07	1.07e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CD44—hematologic cancer	8.52e-07	1.06e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NQO1—hematologic cancer	8.52e-07	1.06e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NUP214—hematologic cancer	8.5e-07	1.06e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3R1—hematologic cancer	8.48e-07	1.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.44e-07	1.05e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NCOR1—hematologic cancer	8.39e-07	1.04e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTM1—hematologic cancer	8.39e-07	1.04e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—EP300—hematologic cancer	8.36e-07	1.04e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.35e-07	1.04e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MTR—hematologic cancer	8.32e-07	1.04e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ABCG2—hematologic cancer	8.32e-07	1.04e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTP1—hematologic cancer	8.32e-07	1.04e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—MTHFR—hematologic cancer	8.3e-07	1.03e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CB—hematologic cancer	8.27e-07	1.03e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CG—hematologic cancer	8.24e-07	1.03e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ENO2—hematologic cancer	8.16e-07	1.02e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYCS—hematologic cancer	8.07e-07	1.01e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CG—hematologic cancer	8.05e-07	1e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.05e-07	1e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	8.01e-07	9.99e-06	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KRAS—hematologic cancer	7.99e-07	9.96e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTT1—hematologic cancer	7.92e-07	9.86e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ABCB1—hematologic cancer	7.88e-07	9.81e-06	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—hematologic cancer	7.84e-07	9.77e-06	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CA—hematologic cancer	7.83e-07	9.75e-06	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CB—hematologic cancer	7.82e-07	9.75e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SDC1—hematologic cancer	7.74e-07	9.64e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NCOR1—hematologic cancer	7.65e-07	9.53e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTM1—hematologic cancer	7.65e-07	9.53e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CREBBP—hematologic cancer	7.64e-07	9.52e-06	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CA—hematologic cancer	7.61e-07	9.49e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CREBBP—hematologic cancer	7.47e-07	9.3e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—MTHFR—hematologic cancer	7.41e-07	9.23e-06	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CA—hematologic cancer	7.34e-07	9.15e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.32e-07	9.12e-06	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—hematologic cancer	7.32e-07	9.12e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CD—hematologic cancer	7.24e-07	9.03e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.21e-07	8.99e-06	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTEN—hematologic cancer	7.15e-07	8.91e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ALB—hematologic cancer	7.15e-07	8.91e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTP1—hematologic cancer	7.11e-07	8.86e-06	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—hematologic cancer	7.1e-07	8.85e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CD—hematologic cancer	7.08e-07	8.82e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ALB—hematologic cancer	6.99e-07	8.71e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CG—hematologic cancer	6.98e-07	8.69e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.88e-07	8.57e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3R1—hematologic cancer	6.84e-07	8.52e-06	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—EP300—hematologic cancer	6.82e-07	8.5e-06	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—hematologic cancer	6.79e-07	8.47e-06	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTEN—hematologic cancer	6.76e-07	8.43e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—MTHFR—hematologic cancer	6.76e-07	8.42e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ABCB1—hematologic cancer	6.73e-07	8.39e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3R1—hematologic cancer	6.69e-07	8.33e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CD44—hematologic cancer	6.58e-07	8.2e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NQO1—hematologic cancer	6.58e-07	8.2e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTM1—hematologic cancer	6.53e-07	8.14e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NCOR1—hematologic cancer	6.53e-07	8.14e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.53e-07	8.14e-06	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—hematologic cancer	6.5e-07	8.1e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CREBBP—hematologic cancer	6.47e-07	8.06e-06	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—EP300—hematologic cancer	6.45e-07	8.03e-06	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—hematologic cancer	6.39e-07	7.97e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CB—hematologic cancer	6.31e-07	7.87e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CG—hematologic cancer	6.23e-07	7.76e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYCS—hematologic cancer	6.23e-07	7.76e-06	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—hematologic cancer	6.22e-07	7.75e-06	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CA—hematologic cancer	6.19e-07	7.71e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	6.19e-07	7.71e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CB—hematologic cancer	6.17e-07	7.69e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CD—hematologic cancer	6.13e-07	7.64e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ALB—hematologic cancer	6.05e-07	7.54e-06	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—hematologic cancer	6e-07	7.48e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.95e-07	7.42e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3R1—hematologic cancer	5.79e-07	7.22e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—MTHFR—hematologic cancer	5.77e-07	7.19e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CREBBP—hematologic cancer	5.77e-07	7.19e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CG—hematologic cancer	5.68e-07	7.07e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTP1—hematologic cancer	5.49e-07	6.84e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CD—hematologic cancer	5.47e-07	6.82e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTEN—hematologic cancer	5.46e-07	6.8e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ALB—hematologic cancer	5.4e-07	6.73e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CB—hematologic cancer	5.34e-07	6.66e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTEN—hematologic cancer	5.33e-07	6.64e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CREBBP—hematologic cancer	5.26e-07	6.56e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—EP300—hematologic cancer	5.2e-07	6.48e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ABCB1—hematologic cancer	5.19e-07	6.47e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3R1—hematologic cancer	5.17e-07	6.44e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.09e-07	6.34e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—EP300—hematologic cancer	5.09e-07	6.34e-06	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—hematologic cancer	5.05e-07	6.3e-06	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CA—hematologic cancer	5.04e-07	6.29e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NCOR1—hematologic cancer	5.04e-07	6.28e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTM1—hematologic cancer	5.04e-07	6.28e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CD—hematologic cancer	4.99e-07	6.22e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ALB—hematologic cancer	4.93e-07	6.14e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CG—hematologic cancer	4.85e-07	6.04e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CB—hematologic cancer	4.77e-07	5.94e-06	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CA—hematologic cancer	4.77e-07	5.94e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3R1—hematologic cancer	4.71e-07	5.87e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTEN—hematologic cancer	4.62e-07	5.75e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CREBBP—hematologic cancer	4.5e-07	5.6e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MTHFR—hematologic cancer	4.46e-07	5.55e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—EP300—hematologic cancer	4.4e-07	5.49e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CB—hematologic cancer	4.35e-07	5.42e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CD—hematologic cancer	4.26e-07	5.31e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ALB—hematologic cancer	4.21e-07	5.25e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTEN—hematologic cancer	4.12e-07	5.14e-06	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—hematologic cancer	4.12e-07	5.13e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3R1—hematologic cancer	4.03e-07	5.02e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—EP300—hematologic cancer	3.93e-07	4.9e-06	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—hematologic cancer	3.9e-07	4.86e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CA—hematologic cancer	3.85e-07	4.8e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CA—hematologic cancer	3.76e-07	4.69e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTEN—hematologic cancer	3.76e-07	4.68e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.74e-07	4.67e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CB—hematologic cancer	3.72e-07	4.63e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—EP300—hematologic cancer	3.58e-07	4.47e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.47e-07	4.33e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CD—hematologic cancer	3.29e-07	4.1e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CA—hematologic cancer	3.26e-07	4.06e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALB—hematologic cancer	3.25e-07	4.05e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTEN—hematologic cancer	3.21e-07	4e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—hematologic cancer	3.14e-07	3.92e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.11e-07	3.87e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—hematologic cancer	3.07e-07	3.83e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—EP300—hematologic cancer	3.06e-07	3.82e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CA—hematologic cancer	2.91e-07	3.62e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.87e-07	3.57e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—hematologic cancer	2.66e-07	3.32e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.65e-07	3.3e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTEN—hematologic cancer	2.48e-07	3.09e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—hematologic cancer	2.38e-07	2.96e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—EP300—hematologic cancer	2.36e-07	2.95e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CA—hematologic cancer	2.27e-07	2.82e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—hematologic cancer	2.17e-07	2.7e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—hematologic cancer	1.85e-07	2.31e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.75e-07	2.18e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—hematologic cancer	1.43e-07	1.78e-06	CbGpPWpGaD
